Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Matassova

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureasTerance Hart, Alba T Macias, Karen Benwell, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cellsAndrew J Massey, Douglas S Williamson, Helen Browne, et al.
Journal of Medicinal Chemistry|April 30, 2011
Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivityAlba T Macias, Douglas S Williamson, Nicola Allen, et al.
RSC Medicinal Chemistry|November 25, 2022
PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discoveryHuiyong Ma, James B Murray, Huadong Luo, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Nature|October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsAndrás Kotschy, Zoltán Szlavik, James Murray, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureasTerance Hart, Alba T Macias, Karen Benwell, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cellsAndrew J Massey, Douglas S Williamson, Helen Browne, et al.
Journal of Medicinal Chemistry|April 30, 2011
Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivityAlba T Macias, Douglas S Williamson, Nicola Allen, et al.
RSC Medicinal Chemistry|November 25, 2022
PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discoveryHuiyong Ma, James B Murray, Huadong Luo, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Oncotarget|May 8, 2018
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growthPatrick Casara, James Davidson, Audrey Claperon, et al.
Nature|October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsAndrás Kotschy, Zoltán Szlavik, James Murray, et al.
Pageof 2